Revvity to acquire Human Cell Design
Engineered immune cells trial to fight colorectal cancer approved
Elix and Axcelead DDP to collaborate on targeted protein degrader discovery
Lotus Neuro launches to deliver therapies across blood-brain barrier
New data from Parkinson’s disease trial
Restoring the “longevity protein”
Positive topline results from phase 2 recurrent ovarian cancer trial
Rare oral cancer has distinct genetic profile
New tool decodes structures and motifs of RNA
Elite immune cells lead fight against multiple myeloma
National framework to strengthen UK advanced therapy clinical trials
Sensor detects Alzheimer’s and Parkinson’s in blood